Teva announced layoffs of 250 employees in June 10, 2026. Teva is cutting 250 jobs at its TAPI active-ingredients unit, over a third of the division's roughly 650 Israel-based staff, as a long-stalled sale of the business drags on. Phased over two years, mostly at its Neot Hovav site near Beer Sheva.